Abstract:AIM: To explore the reversal effect of mifepristone on multidrug resistance (MDR) in drug-resistant human gastric cancer cell line SGC7901/VCR and its mechanisms.METHODS: Expression of multidrug resistance-associated protein(MRP) was detected using reverse transcription-polymerase chain reaction(RT-PCR). Flow cytometry was used to assay the expression of P-glycoprotein(P-gp), Bcl-2, Bax, and the mean fluorescent intensity of intracellular rhodamine 123 in the cells. Meanwhile, the protein levels of Bcl-2 and Bax were also detected by Western blotting analysis. The sensitivity of cells to the anticancer agent, vincrimycin(VCR), and the intracellular [H-3]VCR accumulation were determined by tetrazolium blue (MTT) assay and a liquid scintillation counter, respectively.RESULTS: Expression of MRP and P-gp in SGC7901/VCR cells was 6.04-and 8.37-fold higher as compared with its parental SGC7901 cells, respectively. After treatment with 1, 5, 10, and 20 mu mol/L mifepristone, SGC7901/VCR cells showed a 1.34-, 2.29-, 3.11-, and 3.71-fold increase in the accumulation of intracellular VCR, a known substrate of MRP, and a 1.03-, 2.04-, 3.08-, and 3.68-fold increase in the retention of rhodamine 123, an indicator of P-gp function, respectively. MTT assay revealed that the resistance of SGC7901/VCR cells to VCR was 11.96-fold higher than that of its parental cells. The chemosensitivity of SGC7901/VCR cells to VCR was enhanced by 1.02-, 7.19-, 12.84-, and 21.17-fold after treatment with mifepristone at above-mentioned dose. After 96 h of incubation with mifepristone 10 mu mol/L, a concentration close to plasma concentrations achievable in human, the expression of Bcl-2 protein was decreased to (9.21 +/- 0.65)% from (25.32 +/- 1.44)%, whereas the expression of Bax protein was increased to (19.69 +/- 1.13)% from (1.24 +/- 0.78)% (P<0.01). Additionally, the effects of mifepristone on the expression of Bcl-2 and Bax proteins in SGC7901/VCR cells were further demonstrated by Western blotting analysis.CONCLUSION: Mifepristone has potent reversal effect on MDR in SGC7901/VCR via inhibiting the function of MRP and P-gp, modulating the expression of Bcl-2 and Bax proteins, and enhancing the sensitivity to anticancer agent VCR.

Effects of mifepristone on invasive and metastatic potential of human gastric adenocarcinoma cell line MKN-45 in vitro and in vivo.

INHIBITORY EFFECTS OF MIFEPRISTONE ON THE GROWTH OF HUMAN GASTRIC CANCER CELL LINE MKN-45 IN VITRO AND IN VIVO

Effects of Mifepristone on Proliferation of Human Gastric Adenocarcinoma Cell Line SGC-7901 in Vitro

Effects of Mifepristone on the Growth and Metastasis of Human Gastric Cancer in Vivo and in Vitro

Systems pharmacology of mifepristone (RU486) reveals its 47 hub targets and network: Comprehensive analysis and pharmacological focus on FAK-Src-Paxillin complex

The Architecture and Function of Monoclonal Antibody-Functionalized Mesoporous Silica Nanoparticles Loaded with Mifepristone: Repurposing Abortifacient for Cancer Metastatic Chemoprevention.

[Effects of Hepatocyte Growth Factor Gene Transfection on Adriamycin-Induced Apoptosis of Gastric Cancer Cells in Vitro].

Effect of Mifepristone on Migration and Proliferation of Oral Cancer Cells

Investigation of the 12-Month Efficacy and Safety of Low-Dose Mifepristone in the Treatment of Painful Adenomyosis

Treatment of Endometriosis with Mifepristone Mediated by Nanostructured Lipid Carriers

Reversal of Multidrug Resistance in Drug-Resistant Human Gastric Cancer Cell Line Sgc7901/Vcr by Antiprogestin Drug Mifepristone

Effects of Lncrna ANRIL-knockdown on the Proliferation, Apoptosis and Cell Cycle of Gastric Cancer Cells.

Probe into the Effect of Mifepristone on Angiogenesis of Human Chorionic Villi and Decidual Cells

Effect of Biodegradable Mifepristone Drug Delivery System on the Ultrastructure and Angiogenesis Related Factors of Adenomyosis Cells

Study on effect of cox-2 inhibitor on proliferation and invasion of human gastric cancer cells

Overexpression of ERα Inhibits Proliferation and Invasion of MKN28 Gastric Cancer Cells by Suppressing Β-Catenin

Effects of Estrogen, Progestin and Mifepristone on Endometrial Carcinoma Cell Lines

Study of Establishment of K562/HHT Cell Line and Reversal of Multidrug Resistance by Antiprogestin Drug Mifepristone

REVERSAL EFFECTS OF MIFEPRISTONE ON MULTIDRUG RESISTANCE（MDR） IN DRUG-RESISTANT BREAST CANCER CELL LINE MCF7/ADR IN VITRO AND IN VIVO

Effects of Mifepristone on angiogenesis in human uterine leiomyoma

A new trick for an old dog: The application of mifepristone in the treatment of adenomyosis